Transce3nd LLC bought a new position in shares of Relx Plc (NYSE:RELX – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 878 shares of the technology company’s stock, valued at approximately $40,000.
Several other institutional investors and hedge funds also recently bought and sold shares of RELX. Virtu Financial LLC acquired a new position in shares of Relx in the 3rd quarter valued at $223,000. Wilmington Savings Fund Society FSB acquired a new position in Relx in the third quarter valued at about $125,000. Peapack Gladstone Financial Corp boosted its stake in Relx by 5.7% during the third quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company’s stock worth $234,000 after buying an additional 267 shares during the period. Franklin Resources Inc. increased its position in shares of Relx by 3.3% during the third quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company’s stock valued at $873,000 after acquiring an additional 588 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Relx by 14.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock valued at $39,225,000 after acquiring an additional 104,999 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Relx Trading Up 2.0 %
NYSE:RELX opened at $53.10 on Wednesday. Relx Plc has a 12-month low of $40.25 and a 12-month high of $53.15. The firm has a market cap of $98.28 billion, a PE ratio of 28.55, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The stock has a fifty day moving average price of $49.41 and a 200 day moving average price of $48.09.
Relx Increases Dividend
Wall Street Analyst Weigh In
A number of research firms recently weighed in on RELX. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research report on Wednesday, April 16th. StockNews.com cut Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. Redburn Atlantic initiated coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating for the company. Finally, The Goldman Sachs Group initiated coverage on shares of Relx in a research note on Wednesday, March 26th. They set a “buy” rating on the stock. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Relx has an average rating of “Buy”.
Get Our Latest Research Report on Relx
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Investing in Travel Stocks Benefits
- How to Invest in Micro-Cap Stocks Like a Pro
- What Does Downgrade Mean in Investing?
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- What is Short Interest? How to Use It
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.